The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
In-hospital outcomes of patients with ST-segment elevation myocardial infarction and COVID-19
Oriol Rodriguez-Leor1,2,3; Belen Cid-Alvarez4; Armando Perez de Prado5; Xavier Rossello6,7,2; Soledad Ojeda8; Ana Serrador9,2; Ramon Lopez-Palop10; Javier Martin-Moreiras11,2; Jose Ramon Rumoroso12; Angel Cequier13; Borja Ibañez6,14,2; Ignacio Cruz-Gonzalez11,2; Rafael Romaguera13; Raul Moreno15,2;
1. Institute del Cor, Hospital Universitario Germas Trias i Pujol, Badalona, Spain. 2. CIBER de Enfermedades Cardiovasculares (CIBERCV) Instituto de Salud Carols III, Madrid, Spain. 3. Institut de Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain, Spain 4. Cardiology Department, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, Spain 5. Cardiology Department, Hospital de León, León, España 6. Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. 7.Cardiology Department, Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitari Son Espases, Palma, Spain. 8. Cardiology Department, Hospital Universitario Reina Sofía, IMIBIC, Universidad de Córdoba, Córdoba, Spain 9. Cardiology Department, Hospital Clínico de Valladolid, Valladolid, Spain. 10. Cardiology Department, Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain 11. Cardiology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain. 12. Cardiology Department, Hospital de Galdakao-Usansolo, Galdakao, Vizcaya, Spain 13. Cardiology Department, Hospital de Bellvitge - IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain 14. Cardiology Department, IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain. 15. Cardiology Department, Hospital de La Paz, Madrid, Spain.
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
To assess clinical and prognosis differences in patients with Covid-19 and STEMI.
Methods and results
Using a nationwide registry of consecutive patients managed within 42 specific STEMI-care networks, we compared patient and procedure characteristics and in-hospital outcomes in 2 different cohorts, according to whether they had Covid-19.
Among 1010 consecutive STEMI patients, 91 were identified as Covid-19 (10.9%).
With the exception of smoking status (more frequent in non-Covid-19) and previous coronary artery disease (more frequent in Covid-19), clinical characteristics were similar between groups, but Covid-19 patients had more heart failure on arrival (31.9% vs 18.4%, p=0.002). Mechanical thrombectomy (44% vs 33.5%, p=0.046) and IIbIIIa inhibitors administration (20.9% vs 11.2%, p=0.007) were more frequent in Covid-19 patients, who had an increased in-hospital mortality (23.1% vs 5.7%, p<0.0001), that remained consistent after adjustment for age, sex, Killip class and ischemic time: OR (95% CI) = 4.85 (2.04-11.51); p<0.001. Covid-19 patients had an increase of stent thrombosis (3.3% vs 0.8%, p=0.020) and cardiogenic shock development after PCI (9.9 % vs 3.8%, p=0.007).
Our study revealed a significant increase in in-hospital, stent thrombosis and cardiogenic shock development after PCI in patients with STEMI and Covid-19 in comparison with contemporaneous non-Covid-19 STEMI patients.